Role of SOD2 Ala16Val polymorphism in primary brain tumors

Taş,Ayca; Silig ,Yavuz; Pinarbaşi,Hatice; Gürelik,Mustafa

doi:10.3892/br.2019.1192

Role of SOD2 Ala16Val polymorphism in primary brain tumors

Authors:
- Ayca Taş
- Yavuz Silig
- Hatice Pinarbaşi
- Mustafa Gürelik
View Affiliations

Affiliations: Department of Nutrition and Diet, Faculty of Health Sciences, Sivas Cumhuriyet University, 58140 Sivas, Turkey, Department of Biochemistry, Faculty of Medicine, Sivas Cumhuriyet University, 58140 Sivas, Turkey, Clinic of Neurosurgery, Medicana Sivas Hospital, 58050 Sivas, Turkey
Published online on: February 7, 2019 https://doi.org/10.3892/br.2019.1192
Pages: 189-194

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to investigate the possible association between the genetic polymorphism of the enzyme superoxide dismutase 2 (SOD2, also known as manganese‑dependent SOD), Ala16Val (rs4880), and primary brain tumor risk in the Turkish population. Frequency of the SOD2 gene rs4880 polymorphism was identified in 225 Turkish individuals (120 controls and 105 patients with primary brain tumor) by polymerase chain reaction‑restriction fragment length polymorphism. Subject demographics and clinical characteristics were also recorded. The findings were evaluated using logistic regression and χ2 tests. Logistic regression analysis indicated that smoking did not increase the risk for primary brain tumor [odds ratio (OR)=0.77, 95% confidence interval (CI)= 0.44‑1.33, χ2=0.352, P=0.860]. Similarly, there was no statistically significant difference in the family history of cancer incidence between the control subjects and the primary brain tumor patients (OR=0.81, 95% CI=0.39‑1.71, χ2=0.340, P=0.560). There was no significant association of the histopathological type, genotype/allele frequencies and inheritance models of tumor with the gene variants among the patients with primary brain tumor. In summary, the results of the present study indicated that the Ala16Val polymorphism of the SOD2 gene was not associated with primary brain tumor risk in the Turkish population studied.

View Figures

View References

1	Siegel RL, Miller KD and Jemal A: Cancer statistics, 2018. CA Cancer J Clin. 68:7–30. 2018.PubMed/NCBI View Article : Google Scholar
2	Ricard D, Idbaih A, Ducray F, Lahutte M, Hoang-Xuan K and Delattre JY: Primary brain tumours in adults. Lancet. 379:1984–1996. 2012.PubMed/NCBI View Article : Google Scholar
3	Turkish Cancer Statistics Database: (2015). Department of Cancer Turkish Ministry of Health, 2018 https://hsgm.saglik.gov.tr/tr/kanser-anasayfa
4	Republic of Turkey Ministry of Health General Directorate of Public Health: Turkish Cancer Statistics 2015. http://www.hsgm.gov.tr.
5	Pinarbasi H, Silig Y and Gurelik M: Genetic polymorphisms of GSTs and their association with primary brain tumor incidence. Cancer Genet Cytogenet. 156:144–149. 2005.PubMed/NCBI View Article : Google Scholar
6	Rajaraman P, Melin BS, Wang Z, McKean-Cowdin R, Michaud DS, Wang SS, Bondy M, Houlston R, Jenkins RB, Wrensch M, et al: Genome-wide association study of glioma and meta-analysis. Hum Genet. 131:1877–1888. 2012.PubMed/NCBI View Article : Google Scholar
7	Ishikawa K, Takenaga K, Akimoto M, Koshikawa N, Yamaguchi A, Imanishi H, Nakada K, Honma Y and Hayashi J: ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science. 320:661–664. 2008.PubMed/NCBI View Article : Google Scholar
8	Kumar B, Koul S, Khandrika L, Meacham RB and Koul HK: Oxidative stress is inherent in prostate cancer cells and mediates aggressive phenotype. J Urol. 179 (4s):192–193. 2008.PubMed/NCBI View Article : Google Scholar
9	Klaunig JE and Kamendulis LM: The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol. 44:239–267. 2004.PubMed/NCBI View Article : Google Scholar
10	Tudek B, Winczura A, Janik J, Siomek A, Foksinski M and Oliński R: Involvement of oxidatively damaged DNA and repair in cancer development and aging. Am J Transl Res. 2:254–284. 2010.PubMed/NCBI
11	Klaunig JE, Kamendulis LM and Hocevar BA: Oxidative stress and oxidative damage in carcinogenesis. Toxicol Pathol. 38:96–109. 2010.PubMed/NCBI View Article : Google Scholar
12	Rajaraman P, Hutchinson A, Rothman N, Black PM, Fine HA, Loeffler JS, Selker RG, Shapiro WR, Linet MS and Inskip PD: Oxidative response gene polymorphisms and risk of adult brain tumors. Neuro-oncol. 10:709–715. 2008.PubMed/NCBI View Article : Google Scholar
13	Bag A and Bag N: Target sequence polymorphism of human manganese superoxide dismutase gene and its association with cancer risk: A review. Cancer Epidemiol Biomarkers Prev. 17:3298–3305. 2008.PubMed/NCBI View Article : Google Scholar
14	Tamimi RM, Hankinson SE, Spiegelman D, Colditz GA and Hunter DJ: Manganese superoxide dismutase polymorphism, plasma antioxidants, cigarette smoking, and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 13:989–996. 2004.PubMed/NCBI
15	Wan XS, Devalaraja MN and St Clair DK: Molecular structure and organization of the human manganese superoxide dismutase gene. DNA Cell Biol. 13:1127–1136. 1994.PubMed/NCBI View Article : Google Scholar
16	Pourvali K, Abbasi M and Mottaghi A: Role of superoxide dismutase 2 gene Ala16Val polymorphism and total antioxidant capacity in diabetes and its complications. Avicenna J Med Biotechnol. 8:48–56. 2016.PubMed/NCBI
17	Sutton A, Khoury H, Prip-Buus C, Cepanec C, Pessayre D and Degoul F: The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria. Pharmacogenetics. 13:145–157. 2003.PubMed/NCBI View Article : Google Scholar
18	Kinnula VL, Lehtonen S, Koistinen P, Kakko S, Savolainen M, Kere J, Ollikainen V and Laitinen T: Two functional variants of the superoxide dismutase genes in Finnish families with asthma. Thorax. 59:116–119. 2004.PubMed/NCBI View Article : Google Scholar
19	Lee SJ, Choi MG, Kim DS and Kim TW: Manganese superoxide dismutase gene polymorphism (V16A) is associated with stages of albuminuria in Korean type 2 diabetic patients. Metabolism. 55:1–7. 2006.PubMed/NCBI View Article : Google Scholar
20	Zotova EV, Chistiakov DA, Savost'ianov KV, Bursa TR, Galeev IV, Strokov IA and Nosikov VV: Association of the SOD2 Ala(-9)Val and SOD3 Arg213Gly polymorphisms with diabetic polyneuropathy in patients with diabetes mellitus type 1. Mol Biol (Mosk). 37:404–408. 2003.(In Russian). PubMed/NCBI
21	Taufer M, Peres A, de Andrade VM, de Oliveira G, Sá G, do Canto ME, dos Santos AR, Bauer ME and da Cruz IB: Is the Val16Ala manganese superoxide dismutase polymorphism associated with the aging process? J Gerontol A Biol Sci Med Sci. 60:432–438. 2005.PubMed/NCBI
22	Hiroi S, Harada H, Nishi H, Satoh M, Nagai R and Kimura A: Polymorphisms in the SOD2 and HLA-DRB1 genes are associated with nonfamilial idiopathic dilated cardiomyopathy in Japanese. Biochem Biophys Res Commun. 261:332–339. 1999.PubMed/NCBI View Article : Google Scholar
23	Mitrunen K, Sillanpää P, Kataja V, Eskelinen M, Kosma VM, Benhamou S, Uusitupa M and Hirvonen A: Association between manganese superoxide dismutase (MnSOD) gene polymorphism and breast cancer risk. Carcinogenesis. 22:827–829. 2001.PubMed/NCBI
24	Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 114:97–109. 2007.PubMed/NCBI View Article : Google Scholar
25	Tas A, Atabey M, Caglayan G, Bostanci ME, Sahin Bolukbasi S, Topcu O and Silig Y: Investigation of the association between the MDM2 T309G polymorphism and gastric cancer. Biomed Rep. 7:469–473. 2017.PubMed/NCBI View Article : Google Scholar
26	Zejnilovic J, Akev N, Yilmaz H and Isbir T: Association between manganese superoxide dismutase polymorphism and risk of lung cancer. Cancer Genet Cytogenet. 189:1–4. 2009.PubMed/NCBI View Article : Google Scholar
27	Fisher JL, Schwartzbaum JA, Wrensch M and Wiemels JL: Epidemiology of brain tumors. Neurol Clin. 25:867–890, vii. 2007.PubMed/NCBI View Article : Google Scholar
28	De Roos AJ, Rothman N, Inskip PD, Linet MS, Shapiro WR, Selker RG, Fine HA, Black PM, Pittman GS and Bell DA: Genetic polymorphisms in GSTM1, -P1, -T1, and CYP2E1 and the risk of adult brain tumors. Cancer Epidemiol Biomarkers Prev. 12:14–22. 2003.PubMed/NCBI
29	Gu J, Liu Y, Kyritsis AP and Bondy ML: Molecular epidemiology of primary brain tumors. Neurotherapeutics. 6:427–435. 2009.PubMed/NCBI View Article : Google Scholar
30	American Brain Tumor Association: Brain Tumor Primer - A Comprehensive Introduction to Brain Tumor. 9th edition. ABT Press, 2012.
31	Sathornsumetee S and Rich JN: New approaches to primary brain tumor treatment. Anticancer Drugs. 17:1003–1016. 2006.PubMed/NCBI View Article : Google Scholar
32	Sun GG, Wang YD, Lu YF and Hu WN: Different association of manganese superoxide dismutase gene polymorphisms with risk of prostate, esophageal, and lung cancers: Evidence from a meta-analysis of 20,025 subjects. Asian Pac J Cancer Prev. 14:1937–1943. 2013.PubMed/NCBI
33	Shimoda-Matsubayashi S, Matsumine H, Kobayashi T, Nakagawa-Hattori Y, Shimizu Y and Mizuno Y: Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's disease. Biochem Biophys Res Commun. 226:561–565. 1996.PubMed/NCBI View Article : Google Scholar
34	Wang LI, Miller DP, Sai Y, Liu G, Su L, Wain JC, Lynch TJ and Christiani DC: Manganese superoxide dismutase alanine-to-valine polymorphism at codon 16 and lung cancer risk. J Natl Cancer Inst. 93:1818–1821. 2001.PubMed/NCBI
35	Hung RJ, Boffetta P, Brennan P, Malaveille C, Gelatti U, Placidi D, Carta A, Hautefeuille A and Porru S: Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk. Carcinogenesis. 25:973–978. 2004.PubMed/NCBI View Article : Google Scholar
36	Ambrosone CB, Freudenheim JL, Thompson PA, Bowman E, Vena JE, Marshall JR, Graham S, Laughlin R, Nemoto T and Shields PG: Manganese superoxide dismutase (MnSOD) genetic polymorphisms, dietary antioxidants, and risk of breast cancer. Cancer Res. 59:602–606. 1999.PubMed/NCBI
37	Ergen HA, Narter F, Timirci O and Isbir T: Effects of manganase superoxide dismutase Ala-9Val polymorphism on prostate cancer: A case-control study. Anticancer Res. 27:1227–1230. 2007.PubMed/NCBI
38	Woodson K, Tangrea JA, Lehman TA, Modali R, Taylor KM, Snyder K, Taylor PR, Virtamo J and Albanes D: Manganese superoxide dismutase (MnSOD) polymorphism, α-tocopherol supplementation and prostate cancer risk in the α-tocopherol, beta-carotene cancer prevention study (Finland). Cancer Causes Control. 14:513–518. 2003.PubMed/NCBI
39	Olson SH, Carlson MD, Ostrer H, Harlap S, Stone A, Winters M and Ambrosone CB: Genetic variants in SOD2, MPO, and NQO1, and risk of ovarian cancer. Gynecol Oncol. 93:615–620. 2004.PubMed/NCBI View Article : Google Scholar
40	Rosenblum JS, Gilula NB and Lerner RA: On signal sequence polymorphisms and diseases of distribution. Proc Natl Acad Sci USA. 93:4471–4473. 1996.PubMed/NCBI View Article : Google Scholar
41	Liu Y, Zha L, Li B, Zhang L, Yu T and Li L: Correlation between superoxide dismutase 1 and 2 polymorphisms and susceptibility to oral squamous cell carcinoma. Exp Ther Med. 7:171–178. 2014.PubMed/NCBI View Article : Google Scholar
42	Zhao P, Zhao L, Zou P, Lu A, Liu N, Yan W, Kang C, Fu Z, You Y and Jiang T: Genetic oxidative stress variants and glioma risk in a Chinese population: A hospital-based case-control study. BMC Cancer. 12(617)2012.PubMed/NCBI View Article : Google Scholar